Novel mutations in the 5′-UTR of the FOLR1 gene
-
Anna K. Börjel
Abstract
We have previously reported two novel mutations in the 5′-untranslated region (UTR) of the gene for folate receptor-α (FOLR1). In our search for additional mutations, 92 patient samples with elevated levels of homocysteine were screened by single-strand conformation polymorphism (SSCP) between nt −425 and −782, and −712 and −1110. Between nt −425 and −782 we did not find any mutations. Between nt −712 and −1110 there were three novel mutations. One subject had two mutations very close to each other, c.−856C>T and c.−921T>C. Two subjects had a c.−1043G>A mutation. To get an idea of the prevalence of FOLR1 mutations in an unselected population, we also screened 692 healthy school children for mutations. In this cohort, between nt −188 and +272 we discovered one novel mutation, a single nucleotide substitution, c.−18C>T, in addition to five children with the 25-bp deletion mutation previously described by us. Thus, so far we have discovered six novel mutations in the 5′-UTR region of the gene for folate receptor-α. We genotyped all 17 subjects with a FOLR1 mutation for the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism, and developed new single-nucleotide polymorphism (SNP) genotyping protocols for MTHFR 1298A>C and 1793G>A utilising Pyrosequencing™ technology. None of the 17 subjects had the 677TT genotype, which ruled out this as a cause of elevated homocysteine levels, which was observed in some of the subjects. Further studies of mutations in the 5′-UTR of FOLR1, and in particular of their interplay with folate intake status, are warranted.
References
1. Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 2004; 56:1085–97.10.1016/j.addr.2004.01.002Search in Google Scholar
2. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111–3.10.1038/ng0595-111Search in Google Scholar
3. Elwood PC, Nachmanoff K, Saikawa Y, Page ST, Pacheco P, Roberts S, et al. The divergent 5′ termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure. Biochemistry 1997; 36:1467–78.10.1021/bi962070hSearch in Google Scholar
4. Heil SG, van der Put NM, Trijbels FJ, Gabreels FJ, Blom HJ. Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet 1999; 7:393–6.10.1038/sj.ejhg.5200305Search in Google Scholar
5. Barber RC, Shaw GM, Lammer EJ, Greer KA, Biela TA, Lacey SW, et al. Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet 1998; 76:310–7.10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-TSearch in Google Scholar
6. Zhang G, Zhang QY, Miao XP, Lin DX, Lu YY. Polymorphisms and mutations of the folate receptor-alpha gene and risk of gastric cancer in a Chinese population. Int J Mol Med 2005; 15:627–32.10.3892/ijmm.15.4.627Search in Google Scholar
7. Nilsson TK, Börjel AK. Novel insertion and deletion mutations in the 5′-UTR of the folate receptor-α gene: an additional contributor to hyperhomocysteinemia? Clin Biochem 2004; 37:224–9.10.1016/j.clinbiochem.2003.11.013Search in Google Scholar
8. Guttormsen AB, Schneede J, Ueland PM, Refsum H. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am J Clin Nutr 1996; 63:194–202.10.1093/ajcn/63.2.194Search in Google Scholar
9. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93:7–9.10.1161/01.CIR.93.1.7Search in Google Scholar
10. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001; 98:14853–8.10.1073/pnas.261469998Search in Google Scholar
11. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, et al. Genetic polymorphisms of methyl-enetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas: a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002; 107:162–8.10.1002/ajmg.10122Search in Google Scholar
12. Wakutani Y, Kowa H, Kusumi M, Nakaso K, Yasui K, Isoe-Wada K, et al. A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer's disease. Neurobiol Aging 2004; 25:291–4.10.1016/S0197-4580(03)00082-4Search in Google Scholar
13. Wennlöf AH, Yngve A, Nilsson TK, Sjostrom M. Serum lipids, glucose and insulin levels in healthy school children aged 9 and 15years from Central Sweden: reference values in relation to biological, social and lifestyle factors. Scand J Clin Lab Invest 2005; 65:65–76.10.1080/00365510410003110Search in Google Scholar
14. Börjel AK, Nilsson TK, Wennlöf-Hurtig A, Yngve A, Sjöström M. Plasma homocysteine levels, MTHFR polymorphisms 677C>T, 1298A>C, 1793G>A, and school achievement in a population sample of Swedish children. Clin Chem Lab Med 2005; 43:A16.Search in Google Scholar
15. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62:1044–51.10.1086/301825Search in Google Scholar
16. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, et al. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156:409–15.10.1016/S0021-9150(00)00671-7Search in Google Scholar
17. Ogino S, Wilson RB. Genotype and haplotype distributions of MTHFR677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. J Hum Genet 2003; 48:1–7.10.1007/s100380300000Search in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
